Related Experiment Video
Updated: May 20, 2025

05:55
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
733
An In-Depth Exploration of the Autoantibody Immune Profile in ME/CFS Using Novel Antigen Profiling Techniques
Arnaud Germain1, Jillian R Jaycox2,3, Christopher J Emig4
1Department of Molecular Biology and Genetics, Biotechnology Building, Cornell University, Ithaca, NY 14853, USA.
International Journal of Molecular Sciences
|March 27, 2025
Summary
This study found no significant differences in autoantibody reactivities in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients compared to controls. However, subtle trends in autoantibody ratios and herpesvirus reactivation warrant further investigation in ME/CFS.
Area of Science:
- Immunology
- Neuroscience
- Infectious Disease
Background:
- Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, debilitating disorder with significant physical and cognitive impairments.
- Immune system dysfunction, particularly autoantibodies, is increasingly implicated in ME/CFS pathophysiology.
- Previous studies suggest autoantibodies may play a role, necessitating further investigation into specific antibody-antigen interactions.
Purpose of the Study:
- To comprehensively analyze autoantibody-antigen interactions in a cohort of ME/CFS patients and healthy controls.
- To investigate potential differences in autoantibody profiles, including reactivity against GPCRs and viral proteins, between ME/CFS patients and controls.
- To explore potential sex-based differences in autoantibody reactivities and associations with herpesvirus reactivation in ME/CFS.
Main Methods:
- Utilized two advanced platforms for high-throughput autoantibody profiling: a Luminex panel (1134 autoantibodies) and Rapid Extracellular Antigen Profiling (REAP) (6183 extracellular human proteins, 225 viral proteins).
- Analyzed 7542 antibody-antigen interactions across 172 participants (ME/CFS patients and controls).
- Assessed autoantibody reactivity against specific targets, including GPCRs like β-adrenergic receptors and viral proteins.
Main Results:
- No statistically significant differences in overall autoantibody reactivities were observed between ME/CFS patients and control groups.
- Specific autoantibody reactivities against GPCRs, including β-adrenergic receptors, did not differ significantly between the groups.
- Identified subtle trends in autoantibody ratios between male and female ME/CFS subgroups and observed patterns of herpesvirus reactivation.
Conclusions:
- The study did not find widespread autoantibody differences in ME/CFS patients compared to controls using the analyzed platforms.
- Emerging trends suggest potential sex-specific immune responses and a possible link with herpesvirus reactivation in ME/CFS.
- Further research with broader and more detailed autoantibody profiling is recommended to fully elucidate the role of immune dysfunction in ME/CFS.
Keywords:
GPCRME/CFSantiviral antibodiesautoantibodiesherpesvirusimmunitymuscarinic receptorsβ-adrenergic receptors
